• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Validation of progression-free survival as a surrogate endpoint for overall survival in malignant me

Validation of progression-free survival as a surrogate endpoint for overall survival in malignant me

来源 :第四届广州国际肿瘤学会议 | 被引量 : 0次 | 上传用户：JK0803zhaozhenhong
【摘 要】
：
　　To investigate whether progression-free survival(PFS)can be considered a surrogate endpoint for overall survival(OS)in malignant mesothelioma both at the pa
【作 者】
：
Herbert Pang Lydia Hodgson Xiaofei Wang Stephen George Xiaoyi Wang Nate Foster Daniel Sargent Apar Kishor Ganti Thomas E.Stinchcombe Jeffrey Crawford Robert Krazke Alex Adjei Everett Vokes Hedy Kindle 
【机 构】
：
School of Public Health,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Hong Kong SAR,Ch
【出 处】
：
第四届广州国际肿瘤学会议
【发表日期】
：
2015年期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　To investigate whether progression-free survival(PFS)can be considered a surrogate endpoint for overall survival(OS)in malignant mesothelioma both at the patient and trial level.
其他文献
EXPRESSION AND CLINICAL SIGNIFICANCES OF MAGE-D4,OY-TES-1 AND NY-SAR-35 IN GLIOMA
　　OBJECTIVE: To investigate the expression and clinical significances of tumor antigen MAGE-D 4,OY-TE S-1 and NY-SA R-35 in glioma and evaluate these three an
会议
The miR-24-Bim Pathway Regulates Tumor growth and Angiogenesis in Pancreatic Carcinoma
　　The conventional strategy for cancer therapy offers limited control of specificity and efficacy,study on the molecular mechanism involved in tumor growth an
会议
Cancer evolutionary modeling for precision medicine based therapeutics
会议
Pharmacological inactivation of AKT/ERK and β-Catenin by 7-difluoromethoxyl-5,4'-di-n-octyl gen
　　The epithelial-mesenchymal transition(EMT)has been shown to induce cancer stem traits.However,pharma-therapeutic approach to simultaneously prevent EMT and
会议
Randomized effects of five platinum-based chemotherapy regimens in the first treatment of advanced N
　　OBJECTIVE: To observe efficacy and security of five chemotherapeutic schemes including platinum on advanced nonsmall-cell lung cancer.
会议
Efficacy and security of treatment by bevacizumab and platinum-based on chemotherapy on advanced non
　　Objective: To evaluate efficacy and security of treatment by bevacizumab and platinum on advanced nonsmall-cell lung cancer.
会议
non small cell lung cancerandbevacizumabtreatmentsecurity
The mechanism of bevacizumab combined with cisplatin interfer the invasion and metastasis of lung ad
　　Objective: Research on the mechanism of bevacizumab combined with cisplatin inhibits the invasion and metastasis of Lewis lung adenocarcinoma.
会议
lung adenocarcinomainvasion and metastasisthecisplatinbevacizumab
Entinostat enhance the efficacy of cisplatin to inhibit esophageal squamous cell carcinoma
　　Esophageal squamous cell carcinoma is worse malignancy with high incidence and mortality for Chinese.
会议
LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
　　Background: Leucine-rich-alpha-2-glycoprotein1(LRG1)is a novel oncogene-associated protein which has been clarified vital to the progression of human cancer
会议
Isoform-specific regulation of AKT turn-motif phosphorylation and overall phosphorylation profiles
　　Aberrant AKT activation is prevalent across multiple human cancer lineages,providing an important target for therapy.Phosphorylation plays critical roles in
会议